Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares

Antimicrobial Agents and Chemotherapy
Michele J AndersonMarnie L Peterson

Abstract

Mupirocin decolonization of nasal Staphylococcus aureus prior to surgery decreases surgical-site infections; however, treatment requires 5 days, compliance is low, and resistance occurs. In 2010, 3M Company introduced povidone-iodine (PVP-I)-based skin and nasal antiseptic (Skin and Nasal Prep [SNP]). SNP has rapid, broad-spectrum antimicrobial activity. We tested SNP's efficacy using full-thickness tissue (porcine mucosal [PM] and human skin) explant models and human subjects. Prior to or following infection with methicillin-resistant Staphylococcus aureus (MRSA) (mupirocin sensitive and resistant), explants were treated with Betadine ophthalmic preparation (Bet), SNP, or mupirocin (Bactroban nasal ointment [BN]) or left untreated. One hour posttreatment, explants were washed with phosphate-buffered saline (PBS) plus 2% mucin. One, 6, or 12 h later, bacteria were recovered and enumerated. Alternatively, following baseline sampling, human subjects applied two consecutive applications of SNP or saline to their anterior nares. One, 6, and 12 h after application of the preparation (postprep), nasal swabs were obtained, and S. aureus was enumerated. We observed that treatment of infected PM or human skin explants with SNP resulted ...Continue Reading

References

Dec 1, 1979·Journal of Pharmaceutical Sciences·H U SchenckE Haedicke
Aug 1, 1976·Journal of Clinical Pathology·E T HouangE J Shaw
Apr 1, 1990·Clinical Microbiology Reviews·A D Russell
Jul 1, 1986·Journal of Clinical Microbiology·D Rimland, B Roberson
May 1, 1985·The Journal of Antimicrobial Chemotherapy·M W Casewell, R L Hill
Jan 1, 1995·The Journal of Infectious Diseases·J A KluytmansH A Verbrugh
Dec 1, 1996·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J A KluytmansH A Verbrugh
Jan 1, 1997·Dermatology : International Journal for Clinical and Investigative Dermatology·B Lanker KlossnerF Frey
Apr 29, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A J MangramW R Jarvis
May 24, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M D KalmeijerG A de Baere
Aug 5, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J E VasquezF A Sarubbi
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S HarbarthD Pittet
Feb 13, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Miguel Pérez-FontánFrancisco Valdés
May 11, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·James D WhitehouseDaniel J Sexton
May 15, 2002·Diagnostic Microbiology and Infectious Disease·L M DeshpandeUNKNOWN SENTRY Antimicrobial Surveillance Program Participants Group
Jun 14, 2002·The New England Journal of Medicine·Trish M PerlUNKNOWN Mupirocin And The Risk Of Staphylococcus Aureus Study Team
Mar 5, 2003·The Journal of Antimicrobial Chemotherapy·A UptonH Heffernan
May 9, 2003·Biological & Pharmaceutical Bulletin·Marija BogatajAles Mrhar
Jun 6, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Elaine S WalkerFelix A Sarubbi
Mar 1, 2006·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Pei-Chang WuHsi-Kung Kuo
Aug 3, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H S SaderR N Jones
Aug 26, 2006·The Journal of Hospital Infection·A KonvalinkaI W Fong
Sep 30, 2006·Scandinavian Journal of Infectious Diseases·Håkan RingbergP J Hugo Johansson
Nov 23, 2006·Antimicrobial Agents and Chemotherapy·John D SzumowskiKenneth H Mayer
Mar 27, 2007·The Annals of Thoracic Surgery·Richard EngelmanUNKNOWN Workforce on Evidence-Based Medicine, Society of Thoracic Surgeons
Aug 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeffrey C JonesDavid K Warren
Aug 29, 2007·Antimicrobial Agents and Chemotherapy·Andrew E SimorUNKNOWN Canadian Nosocomial Infection Surveillance Program
Oct 13, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Sarah Klizas WestUNKNOWN Emerging Infections Network, Infectious Diseases Society of America
Feb 15, 2008·Infectious Diseases in Obstetrics and Gynecology·R Beigi, J Hanrahan
Sep 24, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Kanokporn MongkolrattanothaiBarry Gray
Oct 10, 2008·The Cochrane Database of Systematic Reviews·Miranda van RijenJan Kluytmans
Oct 25, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alicia I HidronUNKNOWN Participating National Healthcare Safety Network Facilities
Nov 22, 2008·The Journal of Hospital Infection·C D Owens, K Stoessel
Feb 24, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Heidi S M AmmerlaanMarc J M Bonten
Aug 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean B PatelJohn A Jernigan
Nov 3, 2010·American Journal of Infection Control·Michele J AndersonMarnie L Peterson
Aug 11, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Aisling R CaffreyKerry L LaPlante

❮ Previous
Next ❯

Citations

Mar 31, 2017·Orthopaedic Nursing·Mary Atkinson SmithMelissa Yager
Nov 20, 2016·Médecine et maladies infectieuses·E Botelho-NeversF Lucht
Sep 4, 2017·AORN Journal·Amber Wood
Apr 24, 2019·Expert Review of Anti-infective Therapy·Adèle SakrOlivier Blin
Dec 17, 2019·Anesthesiology·Brooke K DeckerNaomi P O'Grady
Apr 2, 2017·The Bone & Joint Journal·J ParviziT Gehrke
Dec 5, 2019·Annals of Clinical Microbiology and Antimicrobials·Gabrielle S DijksteelBouke K H L Boekema
Jan 8, 2018·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·Daniel S UriasRussell Dumire
Jan 4, 2017·Neuromodulation : Journal of the International Neuromodulation Society·Timothy R DeerNagy Mekhail
Aug 24, 2018·Plastic and Reconstructive Surgery·Sean B Orenstein, Robert G Martindale
Mar 13, 2021·Scientific Reports·Hao WangK Scott Phillips
Jan 21, 2021·Communications Biology·Mark A T BlaskovichMichael Thurn
Dec 23, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Cecelia HarrisonMarci Drees

❮ Previous
Next ❯

Software Mentioned

GraphPad PRISM
GraphPad
Etest

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.